| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8715503 | Journal of the American Academy of Dermatology | 2017 | 8 Pages |
Abstract
A prediction rule was developed and validated to identify patients unlikely to respond adequately to methotrexate. The rule indicates that 4Â weeks of methotrexate might be sufficient to predict long-term response with limited safety risk.
Keywords
DLQIVASPASI75ROCPGAPsoriasis area and severity index (PASI)AUCPhysician's Global AssessmentITTPASIDermatology Life Quality IndexProSIntent-to-treatDiscontinuationMethotrexatevisual analog scalearea under the curvepsoriasis area and severity indexPatient-reported outcomesResponsePredictionreceiver operating characteristic
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Kenneth B. MD, Keith A. PhD, Murali PhD, James E. PhD, Junlong PhD, Meng BS, Eric Q. PhD, Martin M. MD, PhD,